About 50 results
Open links in new tab
  1. Ventilation in ARDS: Why the Debate Persists - Medscape

    Oct 9, 2025 · Dr Aaron Holley explores APRV vs low tidal volume ventilation in ARDS, weighing physiologic promise against the need for definitive clinical evidence.

  2. Levels of PEEP in ARDS - Medscape

    Jan 26, 2005 · What level of positive end-expiratory pressure (PEEP) should you start with in acute respiratory distress syndrome (ARDS) patients? Should you start high and bring it down?

  3. Latest Medical News, Clinical Trials, Guidelines - Medscape

    Mar 6, 2026 · Today on Medscape : Get the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more on Medscape. A free resource for physicians.

  4. Timely Medication Administration Guidelines for Nurses - Page 4

    Oct 16, 2012 · Timely Medication Administration Guidelines for Nurses: Fewer Wrong-Time Errors?

  5. Rituximab: A New Hope for Adult-Onset Nephrotic Syndrome?

    Feb 17, 2026 · Rituximab may be a safe and effective option for frequently relapsing or steroid-dependent adult-onset nephrotic syndrome, with improved relapse-free rates.

  6. Methicillin-Resistant Staphylococcus aureus (MRSA) - Medscape

    May 16, 2025 · Methicillin-Resistant Staphylococcus aureus (MRSA) : Methicillin-resistant Staphylococcus aureus (MRSA) infection is caused by S aureus bacteria and can be fatal. There are …

  7. FDA OKs Skytrofa for Growth Hormone Deficiency in Adults

    Jul 30, 2025 · The FDA has approved the once-weekly injectable lonapegsomatropin -tcgd (Skytrofa, Ascendis Pharma A/S) for replacing endogenous growth hormone in adults with growth hormone …

  8. Q&A: PERT in Exocrine Pancreatic Insufficiency - Medscape

    Aug 20, 2025 · John W. Birk, MD, FACG, a professor of medicine and chief of the Division of Gastroenterology and Hepatology at UConn Health, reviews common pitfalls in PERT use in patients …

  9. Liposomal Irinotecan for Pancreatic Cancer: Is It Worth It?

    May 21, 2024 · Some oncologists have called the regimen a new standard of care, while others aren't convinced that the new first-line pancreatic cancer regimen is worth the high cost.

  10. No-Implant Shunt Wins FDA Breakthrough Status for HF - Medscape

    Jan 9, 2025 · The new approach is designed to create a connection between the left and right atrial chambers of the heart in a single procedure without leaving an implant behind.